Loading…
Helping Experts Accelerate Rare Treatments Act of 2020
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Helping Experts Accelerate Rare Treatments Act of 2020 This bill addresses rare diseases, including by requiring the Food and Drug Administration to ensure the inclusion of rare disease experts and staff members in various parts of the drug review process. The bill also requires certain reports to address issues related to rare diseases and drugs for treating such diseases (sometimes referred to as orphan drugs if the rarity of the disease makes it difficult for the drug to be profitable).
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2021 · third_quarter · Health Issues
H.R. 482/ S. 350, the Newborn Screening Saves Lives Speeding Therapy Access Today (STAT) Act - H.R. 1730/S. 670 Ensuring Lasting Smiles Act H.R. 1916/S. 754 HEART Act of 2020 - H.R. 7567 Reauthorization Act Cures 2.0
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020 H.R. 8467, Access to Rare Indications Act of 2020 Issues related to utilization management tools and rare diseases
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
HR 7567 The Access to Rare Indications Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Pharmacy
The Heart Act (HR 7567)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020 H.R. 8467, Access to Rare Indications Act of 2020 Issues related to utilization management tools and rare diseases
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020 H.R. 8467, Access to Rare Indications Act of 2020 Issues related to utilization management tools and rare diseases H.R. 8467, Access to Rare Indications Act of 2020
Client expense: Not reported · Firm income: Not reported
2020 · third_quarter · Medicare/Medicaid
H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020 H.R. 8467, Access to Rare Indications Act of 2020 Issues related to utilization management tools and rare diseases H.R. 8467, Access to Rare Indications Act of 2020
Client expense: Not reported · Firm income: Not reported
2020 · third_quarter · Health Issues
H.R. 2507: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2019; ALL PROVISIONS OF THE BILL H.R. 4439: CREATING HOPE REAUTHORIZATION ACT; ALL PROVISIONS OF THE BILL H.R. 4712: FAIRNESS IN ORPHAN DRUG EXCLUSIVITY ACT; ALL PROVISIONS OF THE BILL H.R. 7567: HELPING EXPERTS ACCELERATE RARE TREATMENTS (HEARTS) ACT OF 2020; ALL PROVISIONS OF THE BILL H.R. 7647: TO PROVIDE FOR A COVID-19-RELATED DELAY REGARDING ANNUAL LIMITATION ON COST-SHARING FOR GROUP HEALTH PLANS AND INDIVIDUAL AND SMALL GROUP HEALTH INSURANCE COVERAGE; ALL PROVISIONS OF THE BILL S. 2158: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2019; ALL PROVISIONS OF THE BILL S. 4010: CREATING HOPE REAUTHORIZATION ACT; ALL PROVISIONS OF THE BILL GENERAL DISCUSSIONS REGARDING FOOD & DRUG ADMINISTRATION'S COMPLETE RESPONSE LETTER; BREAKTHROUGH THERAPY PROGRAM; HEALTH INNOVATION; NEWBORN SCREENING; VALUE BASED ARRANGEMENTS
Client expense: $230,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE